| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | SYNERLAB GROUP Let's reach success together! Groupe SYNERLAB is a pharmaceutical Contract Manufacturing and Development Organization (CDMO). With six plants in France and Spain, Groupe SYNERLAB offers contract development and manufacturing of medicinal products for human and veterinary use, diagnostic, medical devices and food supplements in various dosage forms: solid dosage forms, non sterile and sterile liquids. Historitically dedicated to contract services, the medium size of the companies of the Groupe SYNERLAB allows to meet customers' requirements with great flexibility and reactivity. The six entities are: Laboratoires BTT - Z.I. de Krafft - 67150 ERSTEIN - France: tablets, hard capsules, betalactams Laboratoires … Type: | 4 | 2 | 1 | 539 |
 |  PhinC Development 15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities … Type: | 6 | 2 | 5 | 15 |
 | LFB Un groupe pharmaceutique spécialiste des médicaments issus du vivant LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies. With a sustained investment in … Type: | 18 | 2 | 12 | 2,258 |
 | Keyrus Life Science The C2RO that helps connect Industry Expertise, Life Data Sciences and Digital Enablement. Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech … Type: | 2 | 2 | 1 | 210 |
 | Biological E. Limited Celebrating Life Everyday Biological E. Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognised vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the … Type: | 4 | 2 | 0 | 3,489 |
 | Evotec #researchneverstops Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and … Type: | 5 | 2 | 3 | 4,958 |
 | Ferring Pharmaceuticals 70 years of building families and helping people live better lives. Guidelines: re.ferring.com/social-guidelines Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries. … Type: | 3 | 2 | 1 | 5,810 |
 | LEO Pharma France [Automatic translation follows] LEO Pharma helps patients have healthy skin. By offering therapeutic solutions in more than 100 countries around the world, LEO Pharma helps people manage their skin problems. Founded in 1908, the pharmaceutical company is fully owned by the LEO Foundation. For decades, LEO Pharma has dedicated its research and development to medicines and solutions for people suffering from skin diseases. The parent company of LEO Pharma is based in Denmark and has around 5,000 employees worldwide. For more information, go to www.leo-pharma.com and www.leo-pharma.fr Dermatology, Thrombosis, Psoriasis, and Atopic Dermatitis Type: | 6 | 2 | 3 | 187 |
 | ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: | 5 | 2 | 3 | 1,124 |
 | TDV SL - A Rephine Company Your GMP Compliance Partner since 1997 TDV will be merging under the Rephine brand from 1st January 2023 and will be renamed Rephine Barcelona S.L.U ********************************************************************************** TDV is a technological consulting company providing services to the Pharmaceutical, Medical Devices and Biotech Industries, related to regulatory compliance, namely GMP, GLP and GCP regulations. Since 1997 the company provides assistance to Life Science companies worldwide, preparing FDA and EMA inspections, providing services for computerised systems validation, process validation, GMP compliance audits, commissioning & qualification, Quality Management Systems and Training Services. The company operates wordlwide from his headquarters in Barcelona, Spain and the … | 2 | 2 | 0 | 13 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO Type: | 3 | 2 | 3 | 115 |
 | Nestlé Health Science Nestlé Health Science is a leader in the science of nutrition, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer care, medical nutrition and pharmaceutical therapies. Headquartered in Switzerland, we have more than 12,000 employees around the world, with products available in more than 140 countries. We see opportunities to improve health through nutrition everywhere. Our expertise areas of active lifestyle nutrition, including vitamins, minerals, herbals and supplements (VMHS), medical nutrition, and pharmaceutical solutions, are rooted in science and cover every facet of health: prevention, maintenance, and treatment. We are redefining the way consumers … Type: | 4 | 2 | 0 | 5,583 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 228 |
 | Abdi Ibrahim Pharmaceuticals İşimiz İyileştirmek Abdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Küçükmustafapaşa, Istanbul at a small pharmacy, by Pharmacist Abdi Nadir İbrahim Bey who had started the “healing” journey. Abdi İbrahim has the largest product portfolio in the sector, with nearly 250 brands and more than 500 products which it develops itself as well as working with 30 licensors. With a powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey’s Pharmaceutical Industry since 2002. Today, Abdi İbrahim, which operates in 17 countries outside Turkey, exports to more than 70 countries ranging from … Type: | 4 | 2 | 0 | 4,384 |
 | Diaceutics PLC Better Testing, Better Treatment At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding … Type: | 4 | 2 | 1 | 200 |
 |  Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care … Type: | 4 | 2 | 1 | 25 |
 | Cipla Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality … Type: | 7 | 2 | 1 | 41,185 |
 | Laboratoire Dielen [Automatic translation follows] The new generation of pharmacy advice products 💊 Since 1978, Laboratoire Dielen has developed and marketed natural health products recognized by pharmacists and doctors. The Dielen Laboratory offers a range of 11 food supplements whose health benefits have been clinically demonstrated. Type: | 4 | 2 | 3 | 32 |
 | Eisai US Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related … Type: | 17 | 2 | 11 | 2,988 |
 | Vetter Pharma Your partner in aseptic filling and packaging We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 6,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and … Type: | 9 | 2 | 6 | 1,921 |
 | FAES FARMA Cuidamos de la salud hoy para construir una sociedad más sana mañana Founded in 1933, Faes Farma is a Spanish pharmaceutical company with a wide international presence. The company conducts research, produces and markets pharmaceutical products and raw materials, exporting to numerous countries. With 1,766 employees and headquarters, manufacturing and R&D center in Leioa (Bizkaia), Faes Farma has offices in Madrid and Barcelona, and subsidiaries in Portugal (Laboratorios Vitoria), Italy (with a 51% stake), Mexico, Guatemala, Colombia, Chile, Peru, Ecuador and Nigeria. Faes Farma also has a division dedicated to Animal Nutrition and Health (FARM Faes), which includes companies such … Type: | 3 | 2 | 0 | 1,171 |
 | Grifols Innovating for patients and society Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, … Type: | 3 | 2 | 1 | 10,773 |
 | Organon France [Automatic translation follows] Official page of Organon France. Improving the health of every woman and making every day a better day. International pharmaceutical laboratory, leader in women's health and major player in the provision of biosimilar drugs and historic drugs with high public health issues. For more information, go to www.organon.fr or follow us on https://twitter.com/OrganonFrance To contact our medical information service: ☎️ 01 57 77 32 00 📩 info.medicale.fr@organon.com Type: | 8 | 2 | 7 | 117 |
 | Rondol Group We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These … Type: | 3 | 2 | 1 | 10 |
 | Pileje [Automatic translation follows] For 30 years, PiLeJe has distributed health solutions aimed at sustainably improving the quality and healthy life expectancy of patients with functional disorders, risk factors or chronic diseases. Complementary to medications, the health solutions developed by PiLeJe are prescribed by health professionals on the basis of individualized advice. To sustainably improve patient health, PiLeJe has expertise in four areas: health through microbiota, micronutrition, phytotherapy and medical nutrition. Key Figures: 300 employees spread across 5 sites in France 318 product references available Present in 35 countries including 6 subsidiaries (Spain, Benelux, Italy, Switzerland, Germany and Sweden) Micronutrition, Individualized … Type: | 10 | 2 | 1 | 478 |
 |  PharmagoraPlus [Automatic translation follows] The national pharmacy exhibition in France | See you on March 8 and 9, 2025 in Paris, Porte de Versailles Creation of new services, digitalization for overall patient care, improvement of the customer experience, reorganization of your pharmacy, increasingly connected patients... There are many changes you must face. To continue to exist tomorrow, your pharmacy must reinvent itself, redesign its businesses and adapt its economic model in order to find new growth levers. Just like your profession, as a national salon, we must also reinvent ourselves. This is why we have dedicated ourselves to all these challenges … Type: | 9 | 2 | 3 | 1 |
 | Grünenthal Group Grünenthal is a global leader in pain management and related diseases. Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain. Grünenthal is headquartered in Aachen, Germany, and has affiliates in 27 countries across Europe, Latin America and the US. Our products … Type: | 2 | 2 | 0 | 4,465 |
 | Orphalan At Orphalan we strive to develop rare disease treatments to improve patients lives. Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. | 3 | 2 | 2 | 106 |
 | Reuters Events Pharma Our mission is to make pharma more open and valued. Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content, around several key topic areas: marketing, commercial, data & analytics, patient engagement, patient advocacy, medical affairs, market access, RWE and clinical. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals … Type: | 19 | 3 | 18 | 14 |
 | Sandoz Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Generics, Biosimilars, and Over the counter medicines Type: | 14 | 3 | 1 | 16,662 |
 | EFPIA - European Federation of Pharmaceutical Industries and Associations Illness never sleeps, so neither can we #WeWontRest The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Twitter : @EFPIA Website : www.efpia.eu Pharmaceutical Industry Type: | 13 | 3 | 11 | 135 |
 | AIS Congress The major mAb Event in France ! We are proud to announce the 10th Antibody Industrial Symposium 2022 (AIS2022) will be held on June 28-29th 2022 in Montpellier, France. This congress, jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign, is part of the series of Industrial Symposia organized by MAbImprove since 2013 (Antibodies Biosimilars, MAbDosing, MAbDelivery, Current & Next Generation Antibody Formats, Antibody Drug Conjugates, Targets for mAbs, Harnessing the Immune System). mAbs, Immunotherapy, Industry, Innovation, Research, drugdiscovery, networking, and B2B Type: | 15 | 3 | 14 | 1 |
 | GIE GERS - Groupement pour l'Elaboration et la Réalisation de Statistiques [Automatic translation follows] The GIE GERS is an economic interest group created by companies in the Pharmaceutical Industry. The GIE GERS is an economic interest group created by companies in the Pharmaceutical Industry. For 45 years, GERS has supported its members in market analysis and performance management and offers unique comprehensive data by pooling data on medicines and health products. GERS plays a key role in the conventional system and economic regulation of reimbursable and hospital medicines. Sell In data is used by health authorities to monitor key market indicators, determine the drug pricing policy based on the level of … Type: | 16 | 3 | 12 | 8 |
 | Recipharm Your innovation, delivered with certainty. Recipharm is an experienced, global CDMO dedicated to meeting pharmaceutical companies’ evolving needs through operational excellence, scientific know-how and customer connectivity. Headquartered in Stockholm, Sweden, we operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering. Our worldwide reach paired with in-depth, localised market knowledge allows us to anticipate our customers’ needs and strengthen the support we provide to forge a healthier, more expansive and more fruitful future together. With a workforce of approximately 9,000 people, we … Type: | 7 | 3 | 0 | 3,526 |
 | CARBOGEN AMCIS BRINGING YOUR SCIENCE TO LIFE CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India). Learn more … Type: | 5 | 3 | 1 | 700 |
 | Bausch + Lomb We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Eye health, ophthalmic pharmaceuticals, ophthalmic surgical products, and contact lens … Type: | 4 | 3 | 1 | 8,527 |
 | Puressentiel The efficacy of nature Created in 2005 by Isabelle and Marco Pacchioni, the Laboratoire Puressentiel is the European leader of aromatherapy products sold in pharmacies, owning 27% of the France market in 2013. In ten years, Puressentiel has developed a range of over 140 products, offering ready-to-use formulas that combine the synergies of essential oils and the purest active ingredients, and are designed to take care of the daily aches and pains of the whole family. Our ranges include products for purifying indoor air, easing joint or muscle pain, improving respiratory well-being, sleep and stress. Natural Medicines, Organic health & … Type: | 10 | 3 | 3 | 427 |
 | OCP Répartition [Automatic translation follows] Leader & Reference for the Pharmacy of Tomorrow OCP at the heart of the health chain OCP is both the leader and the historical referent (1924) of pharmaceutical distribution in France. By providing pharmaceutical logistics and efficient services, OCP is the essential link between laboratories and pharmacists. Every day we contribute to better health. With a territorial network of 41 establishments in France, OCP holds nearly 32% market share and distributes 2 million boxes of medications every day to 16,000 customer pharmacies (including 2,000 hospital pharmacies), from a range of 36,000 references available. OCP is the first … Type: | 14 | 3 | 11 | 1,359 |
 | Hermandad Farmaceutica del Mediterraneo, S.C.L. [Automatic translation follows] Hefame Group Hefame is a cooperative pharmaceutical distribution company founded in 1950. The third company in its sector in the country by turnover volume, in 2021 it exceeded 1,455 million euros. Hefame, today, has the best and most efficient logistics platforms and regulatory warehouses with more than 80,000 m2. Currently, the cooperative has more than 1,000 employees and serves more than 6,000 pharmacies, with nearly 48,000 daily orders and 10,000 daily deliveries. This is possible thanks to its great infrastructure, with distribution warehouses and offices in Albacete, Alicante, Almería, Barcelona, Cartagena, Castellón, Girona, Granada, Madrid, Málaga, Melilla, … Type: | 11 | 3 | 7 | 514 |
 | ISPE Connecting Pharmaceutical Knowledge ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA and the Operations and Training Center in Tampa, Florida, USA. Pharmaceutical Education and Training, Pharmaceutical Guidance Documents, Pharmaceutical Professional Community Building/Networking, Career Solutions, Drug … Type: | 12 | 3 | 6 | 442 |
 | Horus Pharma Horus Pharma is an independent French laboratory specialised in ophthalmology. Founded in 2003, Horus Pharma develops, patents and markets products designed to facilitate eye and eyelid health. Horus Pharma operates in most segments related to ophthalmology and develops practical innovations that combine efficacy and safety. Read our community guidelines https://bit.ly/HPCommunityGuidelines Focused on patient safety, our laboratory has developed recognised expertise in the development of preservative-free formulations and product delivery systems. The product portfolio at the laboratory includes medicinal products, medical devices and food supplements. With its new Surgery Division, Horus Pharma is pursuing its growth by offering surgical and peri-surgical … Type: | 18 | 3 | 16 | 243 |
 | Ferrer We use business to fight for social justice 💙💚 We use business to fight for social justice 💙💚 Chemical, orphan drugs, partnering, hospital products, personal medician, prescripción, and materias primas Type: | 3 | 3 | 0 | 2,018 |
 | Octapharma Our passion drives us to provide new health solutions advancing human life Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs nearly 12,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 195 plasma donation centres across Europe and the US. Octapharma has 40 years of … Type: | 3 | 3 | 0 | 2,431 |
 | Chiesi Group International pharmaceutical Group certified B Corp. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high … Type: | 11 | 3 | 6 | 5,331 |
 | Chiesi France [Automatic translation follows] Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases) , CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) Bringing together nearly 6,500 employees worldwide, CHIESI is present in France across the entire added value chain – R&D, production, distribution and provision to healthcare professionals and patients – with a figure of business reaching nearly €175 million … Type: | 7 | 3 | 4 | 317 |
 | Odimma Therapeutics Empowering Personalized Immunotherapy to Treat Cancer Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has … Type: | 10 | 3 | 8 | 7 |
 | Cercle de Réflexion de l'Industrie Pharmaceutique (CRIP Pharma) [Automatic translation follows] A collective of pharmaceutical company managers on a human scale. CRIP Pharma, a think tank generating ideas to contribute to the evolution of the health environment. CRIP Pharma is leading discussions on the central place of digital technology in the evolution and transformation of the pharmaceutical sector: - A means to develop professions in the sector - Its impact on the health ecosystem, serving the patient, but also to reinvent the interactions between the different actors - A tool to accelerate and maximize efficiency in the sector, from R&D to the patient journey - From denial to … Type: | 26 | 4 | 22 | 14 |
 | NovAliX NovAliX is a preclinical drug discovery-focused CRO NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand … Type: | 27 | 4 | 25 | 379 |
 | Cyclamed [Automatic translation follows] The Cyclamed association, approved by the public authorities, has the mission of collecting and recycling Unused Medicines (UNM) for human use, expired or not, returned by patients to pharmacies. Its objective is to secure the disposal of Unused Medicines, in order to preserve the environment and public health. To these ends, Cyclamed carries out awareness and communication actions among the general public, health professionals and environmental stakeholders. The “Cyclamed Reflex” is a gesture that must be obvious and therefore become a natural gesture. Cyclamed is a non-profit association under the 1901 law bringing together the entire pharmaceutical … Type: | 13 | 4 | 11 | 9 |
 | SynapCell We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such … Type: | 6 | 4 | 3 | 37 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: | 6 | 4 | 2 | 154 |
 | Polepharma La Fabrique [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Pharmaceutical industry and Healthcare industry Type: | 14 | 4 | 13 | 3 |
 | Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: | 6 | 4 | 3 | 494 |
 | Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: | 13 | 4 | 9 | 46 |
 | Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: | 10 | 4 | 8 | 8 |
 | Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a biotechnology company pioneering a breakthrough approach to treat patients suffering from neurodegenerative or neurovascular disorders. Its main drug is a first-in-class monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action. It is demonstrated that one endogenous protease called tissue plasminogen activator (tPA) is implicated in the pathophysiology of neurological diseases such as multiple sclerosis, Parkinson’s disease, stroke and other neurodegenerative disorders through its overexpression and binding to NMDA receptors (NMDAr) present on vascular endothelial cells and regulating the blood brain barrier (BBB) function / … Type: | 13 | 4 | 8 | 12 |
 | Takeda Oncology Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited, is structured to ensure a tight connection from research to development to commercialization and rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to market. Built on a legacy foundation and structured for agility, our leaders have proven experience to drive future growth. We’ve demonstrated leadership in the treatment of hematologic cancers and solid tumors, and we’re now leveraging that expertise to advance cutting-edge science through multiple platforms, partnerships and therapeutic approaches. We are focused on collaborating with leading scientific teams around … Type: | 12 | 4 | 5 | 1,790 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | PharmaVoice Covering everything from Molecule to Market PharmaVoice is for life-sciences executives and other healthcare-service related professionals. The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies, as well as other industry sectors. Additionally, PharmaVoice.com has readers from around the world. Subscribe to the daily newsletter at https://dive.pub/3ruPmUL pharmaceutical, biotechnology, medical devices, life sciences, advertising, marketing, publishing, digital media, editorial, content generation, digital marketing, and marketing strategy Type: | 9 | 5 | 5 | 6 |
 | VALWIN [Automatic translation follows] supports pharmacists in their digital shift and their new missions, by creating their digital platform. 🎯 VALWIN supports pharmacists and groups in their digital transition by creating their digital platforms (website, mobile application, back office) to boost their activity and strengthen the bond with their patients! Our ambition ? Improve the coordination of health professionals around the patient and make the patient an actor in their health 🚀 Digital platforms for pharmacies, Digital platforms for groups, Connected services to connect pharmacists, patients and groups, Prescription reservation, Online sale of medicines and parapharmacy, Secure messaging, A team dedicated … Type: | 9 | 5 | 5 | 16 |
 | ABL GMP PURE-PLAY VIRAL VECTOR CDMO. From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< … Type: | 5 | 5 | 2 | 505 |
 | Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: | 6 | 5 | 2 | 164 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 13 | 5 | 9 | 89 |
 | Unither Pharmaceuticals A world-leading pharmaceutical contract development manufacturing organization (CDMO). Unither Pharmaceuticals, with 8 manufacturing plants (France, USA, Brazil and China) 4 commercial offices and 1 R&D platform, is the worldwide leader in sterile unit-doses contract manufacturing. Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Multidoses with and without preservative, Pharmaceuticals bottles, Suppositories and Pessaries, etc. Our products are sold in more than 100 countries for an annual turnover of 371 million euros. Our vision is to be recognized for making affordable healthcare solutions that improve … Type: | 16 | 5 | 10 | 1,282 |
 | Skyepharma Expert and agile fully integrated CDMO - specializing in classic and complex oral solid forms. Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms. We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services. Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial … Type: | 13 | 5 | 9 | 208 |
 | Biose Industrie Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO Type: | 9 | 5 | 3 | 221 |
 | STRATEGIQUAL SAS Strategiqual is a consulting company located in the center of Paris and operating in Europe, with extensive experience in Europe and the US. Its area of expertise covers pharmaceutical products, medical devices and biotechnology. Strategiqual has in-house expertise in the areas of regulatory affairs, strategic plans, gap analysis, risk analysis, audits, product compliance, quality management systems implementation. Specialties : - Systems approach for designing Quality Management Systems (pharmaceutical products, medical devices, biotechnology) - Drug device combinations (the so called "rule 13" of directive 93/42/CEE) - Innovative medical devices: quality and regulatory approaches; Accès au marché Europe (DM), Accès au marché … Type: | 5 | 5 | 1 | 53 |
 | Viatris Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of … Type: | 17 | 5 | 1 | 15,981 |
 | Veracyte Biopharma Services Gain actionable insights to confidently advance every step of your oncology drug development programs. Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We provide novel insights, expertise and capabilities that empower our biopharmaceutical partners to confidently advance every step of their oncology drug development programs. precision medicine, Biopharma, biomarker signatures, and Cancer care Type: | 18 | 6 | 13 | 93 |
 | DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 14 | 6 | 10 | 119 |
 | Fédération Française des Industries de Santé - FEFIS [Automatic translation follows] The ambition to put its action at the service of public health policy, a source of social and economic progress. Created in 1975, the French Federation of Health Industries – Féfis – brings together eleven professional organizations representing companies which create, manufacture or distribute health products such as human and veterinary medicines, medical devices, optical products, dental products, in vitro diagnostics. A crossroads for exchanges and common actions, Féfis strives to be the spokesperson for a strategic sector of the future for the growth and competitiveness of our country. His commitments within numerous structures – ARIIS, MEDEF, … Type: | 26 | 6 | 21 | 6 |
 | Catalent Pharma Solutions more products. better treatments. reliably supplied. TM Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown … Type: | 6 | 6 | 0 | 13,864 |
 | WeHealthTM by Servier WeHealthTM by Servier wants to improve the patients and HCPs daily live by using digital technologies. WeHealthTM Digital Medicine is the Servier Group’s exciting new eHealth department. Its goal is to deliver an effective response to emerging healthcare market demand for eHealth or connected health, with an approach centered on the patient. WeHealthTM is driven by the spirit of entrepreneurship and intends to invest in innovations created in partnership with startups worldwide. Type: | 10 | 6 | 5 | 8 |
 | Laboratoires Théa Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free Type: | 9 | 6 | 3 | 767 |
 | UPSA [Automatic translation follows] We place people at the heart of our action to support all moments of life. The UPSA laboratory places people at the heart of its action to support all moments of life. Founded in 1935, UPSA is today both a company, with one of the largest pharmaceutical industrial sites in Europe located in Agen, and a brand committed and present in the daily lives of patients and pharmacists. Through its range of family medications, UPSA develops, manufactures and provides medicines to relieve pain and minor everyday ailments, from babies to the elderly and also markets medical devices. … Type: | 12 | 6 | 7 | 1,277 |
 | Arkopharma Faire de la Médecine Naturelle la Médecine de Demain. Arkopharma is a pharmaceutical company founded in 1980 in Carros, near Nice (France), that specializes in the area of phytotherapy, natural medicine and nutritional supplements. Arkopharma is now the European leader in plant-based medicine and nutritional supplements, with an international presence in more than 60 countries. Arkopharma has a dual aim: • To provide natural medicines both for treatment and prevention • To offer healthcare professionals new options for advice and prescriptions Arkopharma in figures: • 1501 employees • 201.3 million euros of consolidated sales • 1,853 registrations and MAs (marketing … Type: | 19 | 7 | 9 | 820 |
 | URGO Group [Automatic translation follows] Invent & Care The URGO Group is committed every day to changing the lives of patients, by putting science at the service of therapeutic progress. It supports healthcare professionals to promote best care practices. 2 PROFESSIONS URGO MEDICAL Faced with the explosion of chronic diseases such as diabetes, Urgo Medical responds to a growing need for care of serious and disabling wounds. We help patients heal better, faster, by developing solutions that have proven their superiority in clinical studies. HEALTHCARE In order to allow everyone to become an actor in their health, our Urgo Healthcare, Juva Santé … Type: | 23 | 7 | 10 | 2,663 |
 | Crossject Expert des médicaments d'urgence auto-administrés Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal … Type: | 16 | 7 | 1 | 94 |
 | CVS Pharmacy Helping people on their path to better health. CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS/pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty departments, photo labs and general merchandise. About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its approximately 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 75 million … Type: | 32 | 8 | 5 | 48,682 |
 | SEQENS Our science for your future SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies. … Type: | 34 | 8 | 28 | 1,272 |
 | G5 Santé [Automatic translation follows] Think tank which brings together the main French health and life sciences companies. The G5 health is a think tank, which brings together the main French health and life sciences companies. BioMérieux, Guerbet, Ipsen, LFB, Pierre Fabre, Sanofi, Servier and Théa are companies that have chosen France as a platform for international development and have made research efforts a priority. On a global scale, the G5 health is a major player with a turnover of more than 47 billion euros and investing more than 7 billion euros in R&D. Type: | 21 | 8 | 16 | 4 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 32 | 11 | 27 | 33 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 33 | 12 | 25 | 69 |
 | Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: | 15 | 14 | 0 | 67,800 |
 | Butterfly Therapeutics (Previously Lucine) The medical device to relieve your pelvic perineal pain. Lucine is part of Butterfly Therapeutics since december 2023. Lucine is an expert in women’s pelvic pain relief, and we’re on a mission to change women’s lives. We offer an evidence-based approach with scientifically proven solutions that reduce & relieve pain related to endometriosis, periods, menopause, post-partum discomfort, and more. Endocare is our clinically-tested, patented medical device that directly targets pain mechanisms with a unique combination of visual and sound frequencies Let's work together, changing women's lives ! Pain, Digital therapeutics, Data, AI, Neurosciences, Sociology, Addiction, Health, Hospital, and CBT Type: | 37 | 15 | 26 | 23 |
 | Eli Lilly and Company For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism. General Information and Guidelines: Eli Lilly and Company strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse. When you engage with Lilly on LinkedIn (and any other of Lilly’s social … Type: | 60 | 16 | 33 | 42,831 |
 | POLEPHARMA [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Polepharma structures the French (bio)pharmaceutical industrial sector and has been supporting its transformation for 20 years. Polepharma has become the first pharmaceutical industrial cooperation in Europe, between areas of excellence and players in the sector: 400+ members, 60% of production & 70k jobs in France. Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma supports its members throughout France. These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, that is to say cutting-edge, virtuous, … Type: | 48 | 27 | 27 | 28 |
SMB